The Utility of Antihistone Antibody Screening in the Diagnosis of Drug-Induced Lupus Erythematosus [7]

Archives of Dermatology

Volumn 140, Issue 4, 2004, Pages 494-495

  Zirwas, Matthew J ^a   Kress, Douglas W ^a   Deng, Jau Shyong ^b  

^a VA Pittsburgh Healthcare System ^*

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ANTIBODY;

AUTOIMMUNE DISEASE; DIAGNOSTIC VALUE; DRUG INDUCED DISEASE; HUMAN; LETTER; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; FEMALE; HISTONES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MASS SCREENING; RETROSPECTIVE STUDIES; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 1842635694     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.4.494     Document Type: Letter

References (5)

1. Fritzler MJ, Tan EM. Antibodies to histone in drug-induced and idiopathic lupus erythematosus. J Clin Invest. 1978;62:560-567.
2. Peng SL, Craft J. Antinuclear antibodies. In: Ruddy S, Harris ED, Sledge CB, eds. Kelley's Textbook of Rheumatology. 6th ed. Philadelphia, Pa: WB Saunders; 2001:166.
3. Kubo M, Ihn H, Yasawa N, et al. Prevalence and antigen specificity of antihistone antibodies in patients with polymyositis/dermatomyositis. J Invest Dermatol. 1999;112:711-715.
4. McGuiness M, Frye RA, Deng JS. Atenolol induced lupus erythematosus. J Am Acad Dermatol. 1997;37:298-299.
5. Rubin RL. Etiology and mechanisms of drug-induced lupus. Curr Opin Rheumatol. 1999;11:357-363.